Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).
Choi J, Lee JH, Koh I, Shim JK, Park J, Jeon JY, Yun M, Kim SH, Yook JI, Kim EH, Chang JH, Kim SH, Huh YM, Lee SJ, Pollak M, Kim P, Kang SG, Cheong JH.
Choi J, et al. Among authors: kim eh, kim sh, kim p.
Oncotarget. 2016 Oct 4;7(40):65643-65659. doi: 10.18632/oncotarget.11595.
Oncotarget. 2016.
PMID: 27582539
Free PMC article.